1. Goudeau A, Coursaget P, Barin F, Dubois F, Chiron JP, Denis F, Diop-Mar J: Prevention of hepatitis B by active and passiveactive immunization. In: Szmuness W, Alter HJ, Maynard JE (eds): Viral Hepatitis, 1981 International Symposium. The Franklin Institute Press, Philadelphia 1982, pp 509–525.
2. Robert Koch-Institut, Berlin: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut — Stand: July 2005 (Recommendations of the Permanent Commission for Vaccinations on Robert Koch-Institute, in German). Epidemiol Bull 2005; 30: 257–274.
3. Couroucé AM, Laplanche A, Benhamou E, Jungers P: Long-term efficacy of hepatitis B vaccination in healthy adults. In: Zuckerman AJ (eds): Viral Hepatitis and Liver Disease. Alan R Liss Inc, New York 1988, pp 1002–1005.
4. Gibas A, Watkins E, Hinkle C, Dienstag JL: Long-term persistence of protective antibody after hepatitis B vaccination of healthy adults. In: Zuckerman AJ (eds): Viral Hepatitis and Liver Disease. Alan R Liss Inc, New York 1988, pp 998–1001.
5. Bell DM, Shapiro CN, Ciesielski CA, Chamberland ME: Preventing bloodborne pathogen transmission from health-care workers to patients — The CDC perspective. Surg Clin North Am 1995; 75: 1189–1203.